Balinatunfib (E5997-GRP)

Balinatunfib (SAR441566) is an oral inhibitor of tumor necrosis factor receptor 1 (TNFR1) signaling. It binds to the central pocket of the soluble TNFα (sTNFα) trimer, alters its configuration, and prevents heterotrimerization with TNFR1 but not TNFR2, thereby blocking TNFR1 signaling. Balinatunfib exhibits anti-inflammatory activity and has the potential for use in autoimmune disease studies.